2Koncz G,Bodor C, K6vesdi D, et al. BCR mediated signal transduction inin.nature and mature B cells. [ J ]. Immunology Letters, 2002, 82 (1-2) :41-49.
3Klonowski KD, Monestier M. Ig heavy-chain gene revision:leaping towards autoimmunity. [J] .Trends Immunol, 2001,22 (7) :400-405.
4Comall RJ, Cheag AM.Rde of Syk in B-cell development and antiegn-receptor signaling. [J]. Proc Nail Acad Sci USA,2000,97(4) : 1713-1718.
5Jurnaa H, Bossaller L,Portugal K,et al. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukacmia. [ J ]. Nature, 2003, 423(6938):452-456.
6Flenaning A, Brummer T, Refit M, et al. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. [J]. Nat Immunol,2003,4(1) :38-43.
7Saijo K, Schmedt C, Su IH. Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. [J]. Nat Immunol,2003,4(3) :274-279.
8zhang Y, Wienands J, Reth M, et al. Induction of antigen receptor expression on B lymphocytes results in rapid competence for signaling of SLP-65 and Syk. [J]. EMBO J, 1998,17(24) :7304-7310.
9Wakabayashi C, Adachi T, Wienands J, ct al. A distinct signaling pathway used by the IgG-containing B cell antigen receptor. [J]. Science,2002,298 ( 5602 ) : 2392-2395.
10Pogue SL, Goodnow CC. C, ene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig) G1 or IgM/IgG1 tail antigen receptors. [J] .J Eep Med,2000,191 (6) : 1031-1044.
